CITO - Centro Integrado de Terapia Onco-Hematológica - Hospital da Cidade de Passo Fundo

Passo Fundo, Rio Grande do Sul 99010-260

0 studies enrolling now · 2 studies all time

What they study most

Malignant Melanoma, Neoplasms, Melanoma

Studies at this site

• A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma — Completed
• A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic Malignancies — Completed